Healthcare - Biotechnology - NASDAQ - US
$ 39.23
-7.43 %
$ 3.03 B
Market Cap
-6.6
P/E
CASH FLOW STATEMENT
-158 M
OPERATING CASH FLOW
-177 M
INVESTING CASH FLOW
646 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
PTC Therapeutics, Inc.
| Net Income | -627 M |
| Depreciation & Amortization | 237 M |
| Capital Expenditures | -121 M |
| Stock-Based Compensation | 131 M |
| Change in Working Capital | -4 M |
| Others | 109 M |
| Free Cash Flow | -279 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | (626.6) | (559.0) | (523.9) | (438.2) | (251.6) | (128.1) | (79.0) | (142.1) | (170.4) | (93.8) | (51.6) | (26.2) | 30.9 |
| Depreciation & Amortization | 236.6 | 128.8 | 64.1 | 84.9 | 32.2 | 26.1 | 17.7 | 3.3 | 2.9 | 2.2 | 2.4 | 2.7 | 2.9 |
| Deferred Income Tax | (46.9) | (34.3) | 0.4 | 5.9 | 8.8 | (0.5) | 0.2 | (0.2) | 2.3 | (19.3) | 92.5 K | (1.8) | (0.5) |
| Stock Based Compensation | 131.2 | 110.3 | 103.5 | 70.3 | 42.1 | 33.3 | 30.6 | 35.0 | 34.0 | 19.3 | 8.4 | 2.3 | 2.8 |
| Other Operating Activities | 151.3 | 82.8 | 128.3 | 46.1 | 49.4 | 27.4 | 7.3 | 9.4 | 2.3 | 21.0 | 6.0 | 0.2 | 0.4 |
| Change in Working Capital | (4.0) | (85.3) | (23.8) | 36.9 | 20.4 | 14.2 | 13.2 | (9.0) | 4.7 | 13.2 | (12.3) | (25.1) | (57.3) |
| Cash From Operations | (158.4) | (356.7) | (251.3) | (194.1) | (98.6) | (27.6) | (10.1) | (103.6) | (124.3) | (57.3) | (46.9) | (47.9) | (20.8) |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | (120.6) | (152.5) | (85.3) | (56.0) | (45.4) | (15.5) | (3.1) | (1.8) | (2.7) | (4.7) | (0.8) | (0.2) | (0.2) |
| Other Items | (56.1) | 442.6 | 304.5 | (505.6) | (341.8) | (27.1) | 16.2 | 106.3 | (18.1) | (140.5) | (127.0) | 0 | 27.9 |
| Cash From Investing Activities | (176.7) | 290.2 | 219.2 | (561.5) | (387.2) | (42.6) | 13.1 | 104.5 | (20.8) | (145.2) | (127.8) | (0.2) | 27.7 |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (381.9) | 148.7 | (2.2) | (46.2) | 267.6 | 0 | 40.0 | 0 | 150.0 | 49 K | (5.0) | (6.9) | (7.2) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1 028.3 | (30.8) | 23.1 | 686.8 | 21.9 | 13.7 | 4.2 | 1.0 | 4.1 | 1.2 | 60.8 | 29.4 | 0 |
| Cash From Financing Activities | 646.4 | 168.0 | 20.9 | 668.7 | 613.2 | 131.6 | 44.2 | 1.0 | 154.1 | 237.1 | 187.4 | 22.4 | (7.2) |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | 314.4 | 98.7 | (19.1) | (79.2) | 126.0 | 57.7 | 53.5 | 0.3 | 8.3 | 34.3 | 12.7 | (25.7) | (0.2) |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | (279.0) | (509.1) | (336.7) | (250.0) | (144.1) | (43.2) | (13.2) | (105.3) | (127.1) | (61.9) | (47.8) | (48.1) | (20.9) |